TLR2-mediated innate immune priming boosts lung anti-viral immunity.

Saved in:
Bibliographic Details
Title: TLR2-mediated innate immune priming boosts lung anti-viral immunity.
Authors: Girkin J; Viral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, Australia.; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; These authors contributed equally., Loo SL; Viral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, Australia.; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; These authors contributed equally., Esneau C; Viral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, Australia.; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Maltby S; Viral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, Australia.; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Mercuri F; Ena Respiratory Pty Ltd, Melbourne, Australia., Chua B; Dept of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Reid AT; Viral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, Australia.; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Veerati PC; Viral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, Australia.; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Grainge CL; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia., Wark PAB; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia., Knight D; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Jackson D; Dept of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Demaison C; Ena Respiratory Pty Ltd, Melbourne, Australia., Bartlett NW; Viral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, Australia nathan.bartlett@newcastle.edu.au.; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
Source: The European respiratory journal [Eur Respir J] 2021 Jul 01; Vol. 58 (1). Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1399-3003
DOI:10.1183/13993003.01584-2020